Trial
Trial for multiple sclerosis drug focused on Hispanic and Black patients
Illustration: Annelise Capossela/Axios
Researchers are conducting what they call a first of its kind clinical trial to study how Hispanic and Bla...
A parish-based multilevel cluster randomized controlled trial to reduce stigma and mental health treatment disparities among Latino communities
doi: 10.1016/j.cct.2023.107080.
Online ahead of print.
Affiliations
Expand
...
Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic
The COVID-19 pandemic has profoundly affected the conduct of community-based and community-engaged research. Prior to the pandemic, our community-b...
State calls additional witnesses in trial challenging Arkansas' transgender health care ban
In a federal trial considering a lawsuit challenging Arkansas’ state law banning gender-affirming care for minors, the state called two addit...
Trial over Arkansas ban on gender-affirming care for transgender youth starts October 17th
LITTLE ROCK, Ark. (KTVE/KARD) — In April of 2021, the Arkansas Legislature passed a bill that banned gender-affirming care for trans youth. Startin...
Barriers to Clinical Trial Participation and Potential Strategies for Enrollment of Hispanic/Latinx Patients With Cancer
Data have demonstrated that Hispanic patients with cancer are often diagnosed at later stages of the disease and have worse quality of life post di...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
